Politician trade (House)

Medpace (MEDP): Rep. David J. Taylor (OH02) disclosed a purchase $1K–$15K

Rep. David J. Taylor (OH02) disclosed a purchase of Medpace in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
4 days
Disclosure lag
Traded
Jan 29, 2026
Disclosed
Feb 2, 2026

What stands out in this filing

  • MEDP closed at $593.07 on Jan 29, 2026, within 5% of its 52-week high, after a 6% rise over the previous 30 trading days.
  • Disclosed 4 days after the trade.
  • Owner named on the report: Filer.
  • 3 disclosures on MEDP by this member on file.
  • 1 other member of Congress disclosed a trade in MEDP within 90 days.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 15, 2026CongressDisclosed sale of MEDP — reported range $15,001 - $50,000
  2. Jan 16, 2026CongressDisclosed sale of MEDP — reported range $1,001 - $15,000
  3. Jan 29, 2026 · this disclosureCongressDisclosed purchase of MEDP — reported range $1,001 - $15,000

What came next

  1. Feb 9, 2026Company filing · Form 8-K · ResultsReported its results
  2. Feb 26, 2026CongressDisclosed purchase of MEDP — reported range $1,001 - $15,000
  3. Apr 21, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results“On April 21, 2026, Jesse Geiger notified the Company of his intent to resign as President and that he will retire from the Company effective May 31, 2026. This departure is not the result of any disagreement with the Company regarding its operations, policies, or practices.”
  4. May 15, 2026Company filing · Form 8-K · Bylaws or charter, Shareholder voteChanged its bylaws, charter or fiscal year, and held a shareholder vote
  5. May 15, 2026Congress · 1 personMembers of Congress: 2 purchases
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Medpace

For Medpace, OQRO holds 6 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MEDP page.

Other recent filings by Rep. David J. Taylor (OH02)

The full history of Rep. David J. Taylor (OH02) is on the profile page.

How this filing works

Explore the data

Common questions

Which member of Congress traded Medpace (MEDP) stock, and how much?

Rep. David J. Taylor (OH02) disclosed a purchase of Medpace in the $1K–$15K range. Reported range, not an exact amount.

When did it happen, and when was it made public?

Traded: Jan 29, 2026. Disclosed: Feb 2, 2026. That is 4 days between the two dates.

What stands out in this filing?

MEDP closed at $593.07 on Jan 29, 2026, within 5% of its 52-week high, after a 6% rise over the previous 30 trading days. Disclosed 4 days after the trade. Owner named on the report: Filer.

Why is the amount a range and not an exact figure?

Members of Congress report each trade in a bracket set by law ($1,001 to $15,000, $15,001 to $50,000, and so on), never an exact amount. OQRO keeps the bracket as filed and does not estimate a figure inside it.

Where does this information come from?

From the House Clerk periodic transaction report, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Medpace recently?

For Medpace, OQRO holds 6 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days. They are listed on the MEDP page.

Does this mean MEDP stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Medpace

Everything OQRO holds on this company is on its MEDP page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data